Publicacións en colaboración con investigadores/as de Pfizer (United States) (3)

2024

  1. A translational framework to DELIVER nanomedicines to the clinic

    Nature Nanotechnology

2017

  1. Cardiovascular efficacy and safety of bococizumab in high-risk patients

    New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539

1988

  1. Inhibitory effect of cabergoline on the development of estrogen-induced prolactin-secreting adenomas of the pituitary

    European Journal of Pharmacology, Vol. 151, Núm. 1, pp. 97-102